1 / 21

Homework Exercise

Homework Exercise. ACCT 70311 . Question 1 (a). Calculate expected enterprise income, RNEA, and residual enterprise income for each year, 2014 – 2019 under GAAP accounting (where R&D expenditures are expensed against income). Question 1(a). Expected enterprise income. Question 1(a).

tamra
Download Presentation

Homework Exercise

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Homework Exercise ACCT 70311

  2. Question 1 (a) • Calculate expected enterprise income, RNEA, and residual enterprise income for each year, 2014 – 2019 under GAAP accounting (where R&D expenditures are expensed against income)

  3. Question 1(a) • Expected enterprise income

  4. Question 1(a) • Expected RNEA

  5. Question 1(a) • Expected residual income

  6. Question 1(b) • Now calculate the RNEA and residual enterprise income for each year under he accounting regime that capitalized R&D expenditures and amortizes them over five years

  7. Question 1(b) • RNEA

  8. Question 1(b) • Residual enterprise income

  9. Question 1(c) • Why are RNEA and residual enterprise income for each year different under the two accounting treatments? • Two major differences: • Under the capitalization approach, deferring depreciation results in a higher EPAT in early years, which favorably affects RNEA and REI • Under the expense approach, large R&D amortization expenses do not occur, which allows for greater RNEA and REI in later years

  10. Question 1(d) • Forecast RNEA for 2020 under the two accounting treatments

  11. Question 1(d) • Forecast REI for 2020 under the two accounting treatments

  12. Question 1(d) • Why do RNEA and REI forecasts differ for 2020? • Forecasts differ because each approach has reached an equivalent steady state for EPAT, but NEA is larger for the capitalized approach because unamortized prior years’ R&D is included as an asset

  13. Question 1(e) • Value the firm at the end of 2013 using the two different accounting treatments • Each approach yields same value • They have each reached steady state

  14. Question 1(f) • If you tried to value this firm by forecasting only to 2016, what difficulties would you face under the two methods? • Steady state would not be reached • REI model would not yield an accurate valuation

  15. Question 1(g) • When R&D is expensed, RNEA is higher despite sales growing at a slower rate in 2016 – 2018 and decreasing in 2019 for two reasons: • R&D expenses are decreasing • Sales are higher than pre-2016 years because more revenue is being generated from the investment in R&D (earlier investments plus current investment)

  16. Question 2(a) • EPAT and NEA under 3y depreciation model

  17. Question 2(a) • EPAT and NEA under 5y depreciation model

  18. Question 2(b) • The forecasts encompassing a 5y estimated life show the firm to be more profitable in 2017 • Why? • Sales are the same under each approach; expenses are less under 5y approach • Investment in plant and equipment is gradually increasing through 2017 • 5y life depreciates 1/5 of each of the past four years’ investment in 2017 • 3y life depreciates 1/3 of each of the past three years’ investment in 2017

  19. Question 2(c) • Calculations to show depreciation method does not affect intrinsic value of firm at the time of the IPO (early 2018)

  20. Question 2(d) • Despite your calculations, the founders insist the market will give a higher value if higher earnings are reported at the time of the IPO. What would be your reply to them? • “I understand your viewpoint sir [or ma’am] (depending on gender of the founder making claim)…” • Five-year depreciation would make earnings higher at the time of IPO • But, the market places strong emphasis on future earnings potential in their valuation of a company • The intrinsic value is the same under either approach

  21. Question 2 (e) The CFO suggests that the focus should be on profits in 2022 (year options vest). What arguments might be made to justify using one depreciation method over the other? • The depreciation method does not affect intrinsic value • Stock price should be same under each method • But, some investors value stock based on earnings multiples • In year of IPO (through 2021) expected earnings are greater if using a 5y depreciable life • Should result in a higher stock price if using multiples • Under 5y depreciable life, earnings will decrease from IPO (2018) through year stock options vest (2022) • The earnings are identical under each depreciation method in 2022, but downward trend in earnings could decrease the stock price if uninformed investors presume the company is deteriorating • It is best to use the depreciation period that most closely represents the assets’ useful economic life

More Related